The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Butbut… it had (simply) Wall Street in its name, so it must have been legit /S
I wonder where Nasdaq is moving, and how, now that the two prices are quite relative to each other. One big difference is the spread, which is very low in Nas, so MM's can't really play their games there, as far as I understand how they work. Small time investors seemed to stay cautious, today, for whatever reason. Maybe soon when the latest news spread more in MS-media the stock price moves faster up? If that will be the case I hope the people here on AIM will hold on to their holdings and don't let the big players begin moving stock to Nas again with easy profit until Nas and AIM prices meet again (by lowering of Nas). You have the power to force the prices to meet higher up this time!
Finally, the two prices seem to have stabilized somewhat to the same price level (much later than I thought). Perhaps the easy stock transfers from AIM to Nas cease for now. At least it's not effortless profit anymore. What will come up next?
This one?
https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/FARN/14481993.html
Not to be a party pooper or anything but these firms require supply chain managers just for clinical trial needs, too.
Maybe he's the big buyer and is waiting to spill the beans? 8)
This is the reason Traumakine exists.
According to studies ARDS mortality rate goes from 35% to 46 % depending on the severity. Ventilators are used on severe patients whose lungs have lost much of their breathing capability, the pressure from ventilator is assumed to recruit these non-used regions. The data regarding the improvement of mortality rate by the use of ventilators on severe cases of ARDS is doubtful at best, negative at worst. It would be absolutely crucial to treat the patient before ARDS gets to severe levels (for which there is no treatment yet).
Source: https://www.uptodate.com/contents/acute-respiratory-distress-syndrome-prognosis-and-outcomes-in-adults
Johnny this is why the people must open their voice and take into action. The least of all take care of your elderly close relatives; pick up that phone.
PS: Much loose stock here in nas
It is all politics now.
Well, excuse the hyperbole. What I meant by that was that it works as it should and as was established in the earlier trials, and that there really is not much chance for any surprises. There has been some questioning about Traumakine possibly having some undiscovered negative effects (Fimea, for example) but the way the kit works makes that pretty farfetched possibility (unless something like surprise corticosteroids happens again).
And as they say.. no one has ever thought of doing this. And it works 100%. The monitoring won't cause any side effects, and the interferon beta-1a effects have been tested on humans long ago by others. I'm an evangelist now. You can look at it yourself, if you want. https://patents.google.com/patent/US20150377885
So the Faron people slyly actually turned this whole thing kinda upside down. The novelity is not in the interferon beta, but in the ARDS monitoring features of Traumakine. Damn I love patent jargon.
Ah, I think I get it. From the (probable) patent itself, I understood that Traumakine is a kit designed for monitoring the development of ARDS in a patient (by following certain biomarkers) and then after certain threshold a treatment (interferon beta-1a - coming with the kit) is administered to stop the fluid buildup.
One thing I've been wondering; what's the difference between Traumakine and the other older interferon beta-1a based medicines. They've been historically (and now) used to treat multiple sclerosis.
Concluded with great success I might add
Sax, that sounds like a phase II trial (A and B) which we have concluded ages ago.
The authorities are going to be very cautious on this issue. They still remember the Pandemrix.
Yeah, Sax is correct on that, although I can't imagine my ramblings having had any effect in the real world (it would be too scary if it did); though my point was also correct and got a bunch of stock on reduced price 8D
I can see the whole thing being sold somewhere else than Finland, though. I don't think Faron's decision makers would oppose it, if Fimea wants to keep sucking their thumbs.